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Phagosomal biogenesis is central for microbial killing and antigen presentation by leukocytes. However, the
molecular mechanisms governing phagosome maturation are poorly understood. We analyzed the role and site
of action of phosphatidylinositol 3-kinases (PI3K) and of Rab GTPases in maturation using both professional
and engineered phagocytes. Rab5, which is recruited rapidly and transiently to the phagosome, was found to
be essential for the recruitment of Rab7 and for progression to phagolysosomes. Similarly, functional PI3K is
required for successful maturation. Remarkably, inhibition of PI3K did not preclude Rab5 recruitment to
phagosomes but instead enhanced and prolonged it. Moreover, in the presence of PI3K inhibitors Rab5 was
found to be active, as deduced from measurements of early endosome antigen 1 binding and by photobleaching
recovery determinations. Though their ability to fuse with late endosomes and lysosomes was virtually elim-
inated by wortmannin, phagosomes nevertheless recruited a sizable amount of Rab7. Moreover, Rab7 recruited
to phagosomes in the presence of PI3K antagonists retained the ability to bind its effector, Rab7-interacting ly-
sosomal protein, suggesting that it is functionally active. These findings imply that (i) dissociation of Rab5 from
phagosomes requires products of PI3K, (ii) PI3K-dependent effectors of Rab5 are not essential for the recruit-
ment of Rab7 by phagosomes, and (iii) recruitment and activation of Rab7 are insufficient to induce fusion of
phagosomes with late endosomes and lysosomes. Accordingly, transfection of constitutively active Rab7 did not
bypass the block of phagolysosome formation exerted by wortmannin. We propose that Rab5 activates both
PI3K-dependent and PI3K-independent effectors that act in parallel to promote phagosome maturation.
Engulfment of pathogens into phagocytic vacuoles is an es-
sential component of the innate immune response (1, 36).
Following formation, the vacuoles or nascent phagosomes ac-
quire microbicidal properties by a maturation process that
involves sequential fusion events with compartments of the
endocytic pathway, culminating with the formation of a hybrid
organelle, the phagolysosome (12, 13, 37). The factors that
initiate and coordinate the maturation process are poorly un-
derstood. By analogy with the progression of the endocytic
pathway, it is thought that Rab GTPases orchestrate the se-
quence of fusion events. Accordingly, Rab5 has been detected
in early phagosomes, where it resides transiently (2, 12, 20, 33)
and Rab7 is present at later stages of maturation (13). In
addition, proteomic analysis identified also Rab2, Rab3,
Rab10, Rab11, and Rab14 as components of the phagosomal
membrane (17).
Rab5 directs the fusion of early endosomes. It is recruited to
endocytic vesicles and is also present in sorting endosomes (5,
18, 26). Bridging between the two compartments, which leads
to their fusion, is thought to be the role of early endosome
antigen 1 (EEA1), an effector that contains two spatially sep-
arate Rab5-binding domains (7, 34). While Rab5 is constitu-
tively associated with sorting endosomes, it is scarce at the
plasmalemma, and it is unclear what mediates its recruitment
to newly formed endocytic vesicles, though a role for RIN1 has
been suggested (35). Even less is known about the mechanism
leading to Rab5 association with nascent phagosomes, which
are equivalent to endocytic vesicles in the maturation se-
quence. It is likely that signals emanating from phagocytic
receptors direct the recruitment of Rab5 to the nascent phago-
some. Prominent among these is the activation of phospha-
tidylinositol 3-kinases (PI3K), which have been recently re-
ported to be essential for proper phagosomal maturation (16,
33, 37). Phagosomes formed by cells treated with wortmannin
had a reduced content of EEA1 (16, 37), consistent with the
notion that Rab5, which serves to anchor it to the membrane,
may not be properly recruited to phagosomes when PI3K is
impaired. However, in addition to its dual Rab5-binding do-
mains, EEA1 has a FYVE domain that binds to phosphatidyl-
inositol 3-phosphate [PI(3)P], a product of the class III PI3K.
Because these kinases are also sensitive to wortmannin, loss of
EEA1 from the phagosomes may have resulted from depletion
of PI(3)P and is not necessarily an indication of Rab5 density
or activity at the membrane. For these reasons, the role of
PI3K in the recruitment and activation of Rab5 remains to be
defined.
Rab7 appears on the phagosomal membrane after Rab5 has
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been recruited and likely resides downstream in the matu-
ration sequence. Indeed, the sole known effector of Rab7,
termed Rab7-interacting lysosomal protein (RILP), is thought
to mediate fusion of late endosomes with lysosomes (8, 21),
and preliminary evidence indicates that it also functions in
phagolysosome formation (R. E. Harrison, C. Bucci, and S.
Grinstein, unpublished observations). Because fusion of pha-
gosomes with lysosomes is precluded by wortmannin, it is con-
ceivable that Rab7 fails to bind or become activated at the
phagosomal membrane, either because Rab5 recruitment is
defective under these conditions or, alternatively, because the
putative connection between Rab5 and the acquisition of Rab7
has been disrupted. These predictions were tested experimen-
tally in the present report. Specifically, we used fluorescent
chimeric constructs of Rab5, Rab7, and RILP, in combination
with fluorescence recovery after photobleaching (FRAP), to
define the kinetics of association and the state of activation of
the GTPases in control and wortmannin-treated phagosomes.
Contrary to our predictions, we found that both Rab5 and
Rab7 are recruited and activated in phagosomes of wortman-
nin-treated cells, implying that PI3K is not required for these
events and is instead involved in parallel and/or downstream
events that are essential for phagosomal maturation.
MATERIALS AND METHODS
Reagents, antibodies, and constructs. Dulbecco’s minimal Eagle’s medium
and fetal bovine serum were from Wisent Inc. HEPES-buffered RPMI, wortmannin,
and human immunoglobulin G (IgG) were from Sigma. The 3-m-diameter latex
beads were from Bangs Laboratories. Sheep red blood cells (RBC) and rabbit
anti-RBC IgG were from ICN-Cappel. N-(3-Triethylammoniumpropyl)-4-(6-[4-
{diethylamino}phenyl]hexatrienyl)pyridinium dibromide (FM4-64) and tetrameth-
ylrhodamine dextran (10,000 kDa) were from Molecular Probes. Anti-lysosomal
associated membrane protein 1 (anti-LAMP-1) antibodies were from the Develop-
mental Studies Hybridoma Bank (Iowa City, Iowa). Anti-c-Myc antibody and goat
anti-EEA1 antibody were from Santa Cruz Biotechnology. The monoclonal anti-
hemagglutinin (anti-HA) antibody was from BabCo (Berkeley, Calif.). The antibod-
ies to lysobisphosphatidic acid (LBPA) have been described earlier (22, 23). Fluoro-
chrome-conjugated secondary anti-human, anti-mouse, anti-rat, anti-rabbit, and
anti-goat antibodies were all from Jackson ImmunoResearch Laboratories.
Cell culture and transfection. Culture conditions for macrophage RAW 264.7
and Chinese hamster ovary cells stably transfected with FcRIIA receptors
(CHO-IIA) have been previously described (37). Where specified, the cells were
treated with 100 nM wortmannin for 30 min at 37°C.
The vector directing the expression of a fusion of syntaxin 13 with green
fluorescent protein (GFP) was described by Collins et al. (10a). The plasmid
encoding RN-tre-GFP was described in reference 24. The vector encoding
RILP-HA was generated by Cantalupo et al. (8). The generation of the plasmids
used for expression of wild-type and mutant forms of either epitope-tagged or
GFP-conjugated Rab5 (S34N and Q79L) and Rab7 (Q67L) is described in detail
elsewhere (6, 32). In all cases the cells were transiently transfected using Fu-
GENE 6 (Roche Molecular Biochemicals) as suggested by the manufacturer.
Phagocytosis assays and wortmannin treatment. Fresh or fixed sheep RBC
were opsonized with rabbit anti-sheep RBC antibody (1:50). Latex beads (3-m
diameter) were opsonized by incubation with human IgG (1 mg/ml) for 1 h at
room temperature or overnight at 4°C. Before phagocytosis the cells were treated
with or without wortmannin in the absence of serum. The cells were incubated at
37°C with either RBC or latex beads for the specified time, excess particles were
washed away with phosphate-buffered saline (PBS), and the cells were incubated
further in culture medium at 37°C for the indicated times. To identify adherent
opsonized RBC or opsonized latex beads that were not internalized, the cells
were incubated for 10 min at 4°C in HEPES-buffered medium containing Cy5-
labeled donkey anti-rabbit IgG or anti-human IgG (1:1,000). Where indicated,
the onset of phagocytosis was synchronized by allowing the particles to bind to
cells on ice for 5 min, and ingestion was then initiated by incubation at 37°C.
Immunofluorescence and confocal microscopy. Prior to immunostaining the
cells were fixed for 60 min in 4% formaldehyde in PBS, permeabilized by
incubation in 0.1% Triton X-100 (vol/vol) in PBS for 20 min, and blocked for 30
min with 5% donkey serum (Gibco-BRL) in PBS (vol/vol). All steps were carried
out at room temperature. For LAMP-1 staining, which is incompatible with the
above protocol, CHO-IIA cells were fixed and permeabilized with methanol.
Permeabilized cells were incubated with primary antibody for 1 h at room
temperature, washed extensively, and then incubated with secondary antibodies
for 1 h at room temperature and washed again. The following primary antibodies
were used at the indicated dilutions: EEA1, 1:50; LAMP-1, 1:4; Myc, 1:200; and
HA, 1:1,000. LBPA immunostaining was performed using a 1:400 dilution, as
previously described (23). Coverslips were then mounted and fixed onto glass
slides using Dako mounting reagent (Dako Corporation). Both live and fixed
cells were analyzed by confocal microscopy using a LSM 510 laser scanning
confocal microscope (Zeiss) with a 100 oil immersion objective. Digital images
were prepared using Adobe Photoshop 6 and Adobe Illustrator 10 (Adobe
Systems Inc.). Quantification of immunofluorescence was performed using NIH
Scion Image software.
To estimate FRAP CHO-IIA cells transfected with WT-Rab5-GFP or CA-
Rab5-GFP were allowed to internalize opsonized 3-m-diameter beads. The
selected phagosome was photobleached using the 488-nm laser line of the Zeiss
LSM 510 confocal microscope at full power, resulting in a 50 to 80% reduction
in the fluorescence intensity. The bleached area was 4 m in diameter, exceeding
the diameter of the phagosome (3 m). The recovery of fluorescence was then
monitored over time by scanning the bleached area at the conventional (low)
laser power to minimize photobleaching during sampling. To analyze the rate of
recovery, we compared the fluorescence of the bleached area to that of an
adjacent unbleached area of the same cell with similar fluorescence intensity. For
each time point, the fluorescence of the bleached area was normalized to that of
the corresponding control (unbleached) area to correct for possible drift of the
focal plane or photobleaching incurred during the low light sampling. A similar
protocol was used to measure FRAP in endosomes. All FRAP measurements
were performed at 37°C.
Uptake of FM4-64. Two types of experiments were performed using the sol-
vochromic dye FM4-64. In one case FM4-64 was used to determine whether early
endosomes had access to preformed phagosomes. For these experiments cells
were allowed to internalize IgG-opsonized particles for 20 min. After phagocy-
tosis, the cells were washed to remove extracellular particles and then cooled and
treated with fluorescein isothiocyanate-labeled donkey anti-human IgG (1:1,000)
for 10 min to identify adherent, incompletely internalized beads. Next, the cells
were pulsed with FM4-64 (1.5 M) for 10 min and immediately analyzed by
fluorescence microscopy.
In the second type of experiment, the lysosomes of RAW or CHO-IIA cells
were prelabeled by incubation with FM4-64 (1.5 M) for 1 h, and this was
followed by a 3-h chase in the absence of the dye. The cells were then challenged
with IgG-opsonized particles. After 20 min at 37°C, the cells were washed,
cooled, and treated as described above to label extracellular beads. Finally, the
phagosomes were allowed to mature by a further incubation for 30 or 60 min at
37°C. As before, the cells were analyzed immediately by fluorescence microscopy
to determine the percentage of FM4-64-positive phagosomes.
All quantitative data are presented as means  standard errors (SE) of the
number of experiments indicated.
RESULTS
Effect of wortmannin on fusion of phagosomes with late
endosomes and lysosomes. Two model systems were employed
throughout this manuscript to analyze phagosome maturation:
RAW264.7 cells, a murine line of monocytes/macrophages,
and CHO-IIA cells. RAW cells were chosen because they are
closely related to primary macrophages, which are professional
phagocytes. However, myeloid cells are notoriously difficult to
transfect, limiting the number of transfected cells available for
analysis. To overcome this problem we also used CHO-IIA
cells that, unlike RAW cells, can be transfected efficiently and
express higher levels of ectopic gene products. CHO-IIA is a
line of engineered phagocytes generated by stable transfection
of cDNA encoding the human FcIIA receptor into Chinese
hamster ovary cells. As described earlier (14), expression of
Fc receptors on the surface of nonphagocytic cells confers
2502 VIEIRA ET AL. MOL. CELL. BIOL.
 o
n
 January 6, 2014 by W








onto them the ability to internalize IgG-coated particles (19).
Moreover, the resulting phagosomes proceed to mature in a
manner that is indistinguishable from that of professional
phagocytes (14).
We tested the effect of wortmannin on the maturation
of phagosomes in CHO-IIA cells. Although phagocytosis is
known to be impaired by wortmannin (4, 11), the effect is
directly proportional to the size of the particles used (11) so
that phagocytosis of beads with diameters of 3 m proceeds
at sufficiently high rates to permit analysis of maturation. We
therefore used 3-m-diameter latex beads opsonized with IgG
for all our studies and identified fully internalized beads by
their inaccessibility to anti-IgG antibodies. Lysosomes were
labeled by pulsing the cells with FM4-64, and this was followed
by a prolonged chase period. FM4-64 is an impermeant solvo-
chromic dye that fluoresces brightly when associated with bi-
ological membranes and can be used to label components of
the endocytic pathway. Lysosomes stained with FM4-64 could
be readily seen to merge with phagosomes within 30 min in
control cells (not shown). By contrast, a profound inhibition of
FIG. 1. Effect of wortmannin on Rab5 acquisition by phagosomes. (A to F) Time-lapse recordings of the distribution of Rab5-GFP during
phagosome maturation. RAW cells were transiently transfected with Rab5-GFP. Untreated (A to C) or wortmannin-pretreated (D to F) cells were
allowed to internalize IgG-opsonized beads while fluorescence images were acquired at regular intervals. The arrows in panels B and E point to
phagosomes that had formed within 1 min of acquisition of the image. (A and D) Corresponding differential interference contrast images. (C and
F) Images of the corresponding fields acquired after an additional 3 min. Scale bars  10 m. (G and H) Quantification of the fraction of
Rab5-positive phagosomes in control (open bars) and wortmannin-treated (black bars) cells as a function of time after phagosome sealing in RAW
(10-min phagocytosis pulse [G]) and CHO-IIA cells (20-min phagocytosis pulse [H]). Note that the time scales are different in these panels. Data
are means  SE (error bars) of four separate experiments each with at least 100 individual phagosomes from 30 different cells expressing low
levels of Rab5-GFP counted per condition.
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phagolysosomal fusion was noted in cells pretreated with wort-
mannin. After 60 min only 13%  6.4% of the phagosomes
contained the lysosomal marker. The maturation process was
seemingly arrested at a comparatively early stage, because
wortmannin also blocked the recruitment to phagosomes of
LBPA, a marker of late endosomes (22, 23). These results
resemble those obtained using professional phagocytes (16,
37), validating the use of CHO-IIA cells to study the role of
PI3K in maturation. It is noteworthy that, while primary mono-
cytes and macrophages express three types of Fc receptors (I,
IIB, and III), the engineered CHO-IIA line expresses only one
(FcIIA). Nevertheless, all the aspects of maturation analyzed
to date in both systems are, at least qualitatively, very similar.
These include phagosomal acquisition of Rab5, PI(3)P, EEA1,
Hrs, Rab7, RILP, LAMP-1, LBPA, and other markers; vacu-
olar ATPase-mediated luminal acidification; and centripetal
motion along microtubules; etc. This implies that a virtually
identical maturation program is triggered by engagement of
different Fc receptors and confirms the usefulness of CHO-
IIA cells in the study of phagosome maturation.
Effect of wortmannin on acquisition of Rab5 by phagosomes.
The role of PI3K in the phagosomal acquisition and activation
of Rab5 was studied next, by transient transfection of a fluo-
rescent fusion protein, Rab5-GFP. As illustrated in Fig. 1A
and C and reported earlier (31), in otherwise-untreated cells
Rab5-GFP can be seen to associate transiently with early
phagosomes. In RAW cells 60% of the phagosomes dis-
played Rab5 following a 10-min phagocytosis pulse, but less
than 10% were stained following a 10-min chase (Fig. 1G). The
kinetics of disappearance was slightly slower in CHO-IIA cells
(Fig. 1H).
We used the irreversible inhibitor, wortmannin, to address
the role of PI3K in Rab5 recruitment. As shown in Fig. 1D to
F, Rab5 also associated with phagosomes formed by wortman-
nin-treated cells. In fact, the fluorescence intensity was rou-
tinely greater in these cells than in untreated control cells
(compare Fig. 1B and E). More strikingly, Rab5 remained
associated with phagosomes for much longer periods in wort-
mannin-treated than in control cells (Fig. 1E to H). After a
10-min chase 30%  5.5% of the phagosomes were Rab5
positive in wortmannin-treated RAW cells, while only 7% 
2.5% were labeled in the controls. The effect was even more
pronounced in CHO-IIA cells, where little disappearance was
apparent even after a 20-min chase. Thus, the inhibition of
phagosome maturation induced by wortmannin cannot be at-
tributed to the failure to recruit Rab5 and may instead be due
to differences in its state of activation.
Rab5 is active in phagosomes of wortmannin-treated cells.
Rab proteins exist in active (GTP-bound) and inactive (GDP-
bound) states. We investigated whether wortmannin prevents
the activation of the Rab5 detected on the phagosomal mem-
brane. Several criteria were applied to assess the state of
Rab5 activation in situ. First, we measured the interaction of
EEA1 with phagosomes. Because the Rab5-binding domains
of EEA1 recognize only the GTP-bound form of the protein,
the extent of association can be used to monitor the state of
activation of Rab5. It must be borne in mind, however, that
EEA1 can attach to PI(3)P on the phagosomal membrane via
its FYVE domain. However, elimination of PI(3)P by inhibi-
tion of PI3K results only in partial displacement of EEA1 (Fig.
2E), implying that the latter has additional sites of attachment,
likely via active Rab5. This assumption was tested by transfect-
ing cells with Rab5(S34N), a dominant-negative form of the
GTPase (DN-Rab5). The effectiveness of this inhibitory con-
struct was first validated by monitoring the rate of fluid phase
endocytosis, which is known to require active Rab5 (25). Ex-
pression of DN-Rab5 prevented uptake of labeled dextran
FIG. 2. Effect of dominant-negative Rab5 on fluid phase uptake
and EEA1 acquisition. CHO-IIA cells were transiently transfected
with dominant-negative Rab5-GFP (DN-Rab5). (A and B) The cells
were incubated for 30 min in medium containing rhodamine-dextran
(100 g/ml) to assess fluid phase intake. (C and D) The cells were
allowed to internalize IgG-opsonized beads for 20 min, and this was
followed by fixation and EEA1 immunostaining. (A and C) GFP flu-
orescence; (B) fluorescence of rhodamine-dextran; (D) distribution of
EEA1. Asterisks identify transfected cells. Arrows point to phago-
somes. In panel B, transfected cells are outlined to facilitate identifi-
cation of their boundaries. Scale bar  10 m. (E) Quantification of
the effects of DN-Rab5 and wortmannin (Wort) on EEA1 acquisition
by phagosomes in CHO-IIA cells. Cells were allowed to internalize
beads for 20 min, fixed, and immunostained for EEA1. Where indi-
cated, cells were pretreated with 100 nM wortmannin for 30 min. The
cells were analyzed microscopically, and phagosomes lined by clearly
observable EEA1 were scored. Data are means  SE (error bars) of
four separate experiments, each with at least 100 individual phago-
somes from 30 to 40 different cells counted per condition.
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(Fig. 2A and B) yet had no discernible effects on phagocytic
efficiency; in four experiments the phagocytic index was statis-
tically indistinguishable in control and DN-Rab5 expressing
cells (362  41 and 359  35 particles/100 cells, respectively).
More importantly, the dominant-negative Rab5 also elimi-
nated the wortmannin-resistant fraction of EEA1 binding to
phagosomes (Fig. 2C, D, and E), implying that this component
is mediated by the active, GTP-bound form of Rab5. Similar
effects were noted 10 and 20 min after phagocytosis. The ef-
fects of DN-Rab5 could be studied only in CHO-IIA cells,
because the low levels of expression attained in RAW cells
were insufficient to prevent fusion of endosomes with phago-
somes or the clathrin-mediated endocytosis of aggregated IgG,
which is blocked by the dominant-negative construct in CHO-
IIA cells (not illustrated). These findings stress the usefulness
of CHO-IIA in instances where high levels of ectopic expres-
sion of a protein are required.
The ability of wortmannin-treated phagosomes to bind
EEA1 in a DN-Rab5-sensitive manner suggests that Rab5 is at
least partly active in cells treated with the inhibitor. In an
attempt to confirm this notion, we measured the ability of
phagosomes to fuse with early endosomes in control and wort-
mannin-treated cells. Because Rab5 is thought to mediate fu-
sion of phagosomes with early endosomes (2, 20), we reasoned
that delivery to the phagosomal lumen of a marker trapped in
early endosomes could be used as an index of Rab5 activity.
FIG. 3. Effect of wortmannin on fusion of nascent phagosomes with early endosomes. (A to F) CHO-IIA cells that were untreated (A to C)
or pretreated with wortmannin (D to F) were allowed to internalize IgG-opsonized latex beads for 20 min. After washing excess beads, the cells
were incubated briefly on ice with anti-human antibody conjugated with fluorescein isothiocyanate to identify adherent, incompletely internalized
beads (B and E). The cells were then incubated for an additional 10 min at 37°C with FM4-64.The red fluorescence of FM4-64 is shown in A and
D (arrows). C and F are the differential interference contrast images corresponding to A and D, respectively. (G to I) CHO-IIA cells transiently
transfected with syntaxin 13-GFP were treated with wortmannin (H and black columns in I) or left untreated (G and empty columns in I) and
allowed to internalize particles for 20 min. Adherent, incompletely internalized beads were then stained as above using Texas red-conjugated
antibodies. Lastly, the cells were chased for the indicated times and fixed, and confocal fluorescence microscopy was used to visualize the
distribution of syntaxin 13. (G and H) representative fluorescence images, with corresponding differential interference contrast insets. Arrows point
to phagosomes. Scale bars 10 m. (I) Quantitation of the effect of wortmannin on syntaxin 13 acquisition by phagosomes. Data are means 
SE (error bars) of three separate experiments, each with at least 100 individual phagosomes from 30 to 50 different cells counted.
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Such experiments are illustrated in Fig. 3. The cells were ini-
tially allowed to internalize opsonized latex beads for 20 min.
Next, beads that were bound but not yet internalized were
identified by addition of anti-IgG at 4°C (e.g., Fig. 3B and E).
This step was essential to differentiate delivery of endosomal
markers to a preformed phagosome, from merely trapping the
fluid-phase marker during phagosome formation. Then, early
endosomes were loaded with FM4-64 and fusion of newly
formed endosomes with preformed phagosomes was moni-
tored by confocal microscopy for the next 10 min. Fusion of
early endosomes with phagosomes, revealed by the appearance
of a rim of FM4-64 fluorescence around the phagocytic parti-
cle, was readily detectable in control cells (Fig. 3A to C) but
also in wortmannin-treated cells (Fig. 3D to F). Similar results
were obtained using RAW cells (not illustrated). That fusion
of phagosomes with early endosomes persists after treatment
with wortmannin was also demonstrated by monitoring the
distribution of the early endosomal marker syntaxin 13 (28).
Cells were transfected with a GFP fusion of this early endo-
somal SNARE and analyzed after ingestion of opsonized
beads. As illustrated in Fig. 3G and H and summarized in Fig.
3I, endosomes containing syntaxin 13 merged with phagosomes
to a similar extent and comparable kinetics in both control and
wortmannin-treated cells. Very similar results were obtained
with RAW cells (not shown). Together, these results suggest
that fusion-competent, presumably GTP-bound Rab5 is pres-
ent on the membrane of wortmannin-treated phagosomes.
FRAP was used as a final criterion to assess the state of
activation of Rab5 on wortmannin-treated phagosomes. Be-
cause the rate of dissociation of Rab GTPases from mem-
branes is thought to be determined by the conversion of the
GTP-bound to the GDP-bound forms, measurements of the
rate of Rab5 exchange from the phagosome should provide an
indication of its activation state. Dissociation rates can be
inferred from the rate of fluorescence recovery after an or-
ganelle expressing a labeled protein has been photobleached.
This approach was recently used successfully to assess the
effect of RILP on the activation state of Rab7 (21). We there-
fore compared the rate and extent of FRAP of Rab5 in phago-
somes and endosomes. The latter were used to validate the
sensitivity of the assay. Cells were transfected with GFP fusions
of either wild-type Rab5-GFP or Rab5(Q79L), a constitutively
active mutant (CA-Rab5). Typical FRAP measurements in
endosomes are illustrated in Fig. 4A. Following bleaching of
wild-type Rab5, recovery was fast (half-life  5.2 s) and nearly
complete (fractional recovery  92.3%  4%; see Fig. 4A).
This implies that most of the endosomal Rab5 turns over
rapidly, dissociating when GTP is hydrolyzed and reassociating
when GDP is exchanged for GTP. Accordingly, when consti-
tutively active Rab5-GFP was expressed, recovery after photo-
bleaching was very poor. Only 35.8%  4% recovery was
achieved after 200 s, the longest time studied. Having validated
the use of FRAP, we proceeded to analyze the behavior of
phagosomes treated with wortmannin (normal phagosomes
could not be studied because the short time of residence of
wild-type Rab5 in untreated cells precludes FRAP studies). As
shown in Fig. 4B, the recovery of fluorescence was poor in
wortmannin-treated phagosomes (48.4%  5%), implying that
Rab5 is largely in the active state. In accordance with this
interpretation, the extent of the recovery was only slightly
greater than that of constitutively active Rab5 (32.5%  3%).
In both instances, part of the recovery is likely due to lateral
diffusion of a fraction of fluorescent Rab5 that remains un-
bleached at the poles of the phagosome, which lie outside the
focal plane of the bleaching laser. Under the conditions used,
a depth of only about 1.8 m, less than the diameter of the
phagosome, was effectively bleached (unpublished observa-
tions). Of interest, treatment with wortmannin also greatly
reduced the fraction of endosomal Rab5 that recovered after
photobleaching (Fig. 4A), implying that products of PI3K are
also required for deactivation of this GTPase in endosomes.
Jointly, the EEA1, FM4-64, syntaxin 13, and FRAP experi-
ments indicate that Rab5 is largely in the active state in phago-
somes formed by wortmannin-treated cells.
FIG. 4. Rab5-GFP FRAP. CHO-IIA cells were transfected with either wild-type (WT) or constitutively active (CA) Rab5-GFP. Where
indicated, the cells had been pretreated with wortmannin (Wort). (A) Labeled endosomes were identified and their initial fluorescence quantified
and defined as 100%. Bleaching was then performed and fluorescence recovery monitored as described in Materials and Methods. (B) Cells
transfected with WT-Rab5 were treated with wortmannin, while cells transfected with CA-Rab5 were left untreated. The cells were then allowed
to ingest opsonized beads, fluorescent phagosomes were identified, and FRAP was measured as above. Representative experiments are shown in
the main panels. The inset tables show the corresponding times for 50% recovery (T1/2) and the fractional recovery (R). Data in the tables are
means  SE (error bars) of 8 to 10 determinations, each involving 10 different cells.
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Overexpression of DN-Rab5 arrests phagosome maturation.
While earlier evidence had demonstrated that wortmannin
blocks phagolysosome formation (16, 37) (see above), the ex-
periments summarized above showed that Rab5 is active in the
membrane of phagosomes treated with the PI3K inhibitor.
Two explanations may account for these observations: (i) the
PI3K-dependent step may lie downstream or on an arm of the
fusogenic pathway that is parallel to that involving Rab5, or (ii)
Rab5 may not be part of the pathway required for phagosome
fusion with lysosomes. While Rab5 is known to be an essential
component of progression along the endocytic pathway (5; for
a review, see reference 39), the role of Rab5 in phagosome
maturation has not been addressed directly.
The requirement for Rab5 in phagosome maturation was
tested by overexpression of DN-Rab5. CHO-IIA cells were
used for these studies, to attain higher levels of the inhibitory
protein. As shown in Fig. 5A and B incorporation of LAMP-1,
a late endosomal/lysosomal marker, into the phagosomal
membrane was greatly reduced by expression of DN-Rab5. In
3 experiments, inhibition averaged 72%  3.9% (Fig. 5E).
Rab7 associates with phagosomes following acquisition of
Rab5 and, by analogy with the endosomal pathway, is likely
involved in directing fusion with lysosomes. We therefore an-
ticipated that recruitment of Rab7 by phagosomes would re-
quire the prior activation of Rab5. This prediction was verified
in the experiments summarized in Fig. 6. Cells were cotrans-
fected with myc epitope-tagged Rab7 and either GFP or DN-
Rab5-GFP. Rab7 association with late phagosomes was readily
detectable in cells transfected with GFP (Fig. 6B), while those
expressing the inhibitory Rab5 had much reduced staining
(Fig. 6E). In four separate experiments, Rab7 recruitment was
depressed by 66% at all the times analyzed (Fig. 6G). There-
fore, Rab5 seems to be essential for normal phagosome mat-
uration.
Overexpression of a Rab5-GTPase activating protein ar-
rests phagosome maturation. The role of Rab5 in maturation
was confirmed using RN-tre, a Rab5 GTPase-activating pro-
tein (GAP) (24). Overexpression of a GTPase activator is
expected to minimize the ability of Rab5-GTP to interact with
its effectors. CHO-IIA cells were transfected with RN-tre-GFP
and successful expression was verified by direct fluorescence
microscopy (Fig. 5C). Fluid phase pinocytosis was depressed in
cells expressing RN-tre, implying that the concentrations at-
tained were sufficient to inhibit Rab5 (not illustrated). Expres-
sion of RN-tre-GFP did not affect the phagocytic efficiency
and the GTPase was detectable on the membrane of nascent
phagosomes. Importantly, overexpression of RN-tre-GFP
profoundly depressed the ability of phagosomes to acquire
LAMP-1 (Fig. 5D and E). The extent of inhibition was similar
to that observed in DN-Rab5 transfected cells (Fig. 5E).
Jointly, these findings imply that active Rab5 is required for
fusion of phagosomes with late endosomes and/or lysosomes.
Effect of wortmannin on Rab7 acquisition. As Rab5 acqui-
sition and activation are not dependent on the presence of
PI(3)P on the phagosome, we next determined whether the
recruitment of Rab7 to the phagosome is affected by wortman-
nin. RAW and CHO-IIA cells were transiently transfected with
a construct encoding Rab7-GFP. When appropriate levels of
the fusion protein were expressed, the cells were either treated
with wortmannin or left untreated and next challenged with
opsonized beads. The presence of the fluorescent chimera on
phagosomes was monitored by confocal microscopy. Rab7
could be readily detected on the membrane of control phago-
somes (Fig. 7A). In CHO-IIA cells 79%  6.4% of the phago-
somes were Rab7-positive 20 min after initiation of ingestion
and this number increased, approaching 100% over the next 30
min (Fig. 7E). Very similar results were obtained in RAW cells
FIG. 5. Role of Rab5 in fusion of phagosomes with late endocytic
compartments. CHO-IIA cells were transfected with DN-Rab5-GFP
(A, B and black column in E) or with RN-tre-GFP (C, D, and gray
column in E). Transfected cells (labeled by asterisks) are identifiable
by their green fluorescence (A and D). The cells were allowed to
internalize opsonized beads for 20 min. After washing unbound beads,
incubation at 37°C proceeded for 30 more min. The cells were then
fixed, permeabilized with methanol at20°C, and stained for LAMP-1
(B, D, and E). Arrows and arrowheads point to LAMP-1-positive and
-negative phagosomes, respectively. Scale bars  10 m. (E) Quanti-
fication of the effect of DN-Rab5 (black column) and RN-tre (gray
column) overexpression on LAMP-1 acquisition by phagosomes, com-
pared to untransfected control cells (open bar). Results shown are
means  SE (error bars) of three separate experiments, each with at
least 100 phagosomes from 20 to 40 different cells counted.
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(Fig. 7F). As illustrated in Fig. 8C and summarized in Fig. 7E
and F (black columns), wortmannin treatment attenuated, but
did not prevent, the acquisition of Rab7 by the phagosome.
Over 50% of phagosomes were Rab7 positive immediately
after the ingestion pulse (a 40% inhibition compared to con-
trol), and this fraction changed only marginally thereafter in
both CHO-IIA (Fig. 7E) and RAW cells (Fig. 7F).
PI3K activity is not necessary for Rab7 activation. The mod-
est decrease in Rab7 recruitment documented in Fig. 7 cannot
fully explain the much greater (90%) inhibition of lysosomal
fusion produced by wortmannin. Two possible mechanisms
could explain this quantitative discrepancy: products of PI3K
may be required for Rab7 activation, independently of its re-
cruitment, or alternatively, the kinase may be required for a
separate event that, in parallel with Rab7, may be essential for
successful phagolysosome formation.
To differentiate these hypotheses, we tested the state of
activation of Rab7 in cells treated with wortmannin. Members
of the Rab family bind their effectors only when bound to GTP,
i.e., in their active configuration. We therefore determined
FIG. 6. Effect of dominant-negative Rab5 on Rab7 acquisition. CHO-IIA cells were cotransfected with wild-type Rab7-myc and either GFP (A
to C and empty columns in G) or with DN-Rab5-GFP (D to F). The cells were incubated for 20 min with IgG-opsonized beads, chased for the
indicated times, and then fixed, permeabilized, and immunostained. (A and D) Green fluorescence; (B and E) distribution of Rab7, revealed by
immunostaining the myc epitope; (C and F) corresponding differential interference contrast images. Arrows and arrowheads point to Rab7-myc
positive and -negative phagosomes, respectively. Scale bars  10 m. (G) quantification of the effect of DN-Rab5 on Rab7 recruitment by
phagosomes, from experiments like those in panels A to F. Empty columns, control; black columns, cells transfected with DN-Rab5-GFP. Results
shown are means  SE (error bars) of four separate experiments, each with at least 100 individual phagosomes counted per condition in cells with
high expression levels of DN-Rab5.
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whether Rab7 is capable of recruiting effectors following treat-
ment with the PI3K inhibitor. To date, only one effector of
Rab7, termed RILP, has been identified (8, 21). Experiments
analyzing the distribution of RILP are depicted in Fig. 8.
CHO-IIA and RAW cells were cotransfected with Rab7-GFP
and with an epitope-tagged form of RILP and their distribu-
tion was monitored by confocal microscopy. As reported (8,
21), RILP accumulated in a juxtanuclear complex, near the
microtubule-organizing center. In addition, in cells that had
ingested particles but were otherwise untreated, RILP was
found in the vast majority of phagosomes that contained Rab7
(Fig. 8A to C). Of note, RILP was also found in most of the
Rab7-positive phagosomes in wortmannin-treated cells (Fig.
8D to F). This observation implies that PI3K is not essential for
the activation of Rab7 and that the large fraction of Rab7
recruited to phagosomes in wortmannin-treated cells is capa-
ble of binding effectors.
The preceding data imply that the site of action of wortman-
nin is at a step that occurs in parallel with, or after activation
of Rab7. This conclusion was validated using Rab7(Q67L), a
GTPase-deficient and therefore constitutively active form of
Rab7 (CA-Rab7). We predicted that if wortmannin prevents
phagolysosome formation by interfering with the activation of
Rab7, expression of the constitutively active mutant would
FIG. 7. Effect of wortmannin on Rab7 acquisition by phagosomes. CHO-IIA cells (A to E) or RAW cells (F) were transfected with wild-type
Rab7-GFP. The cells were either left untreated (A, B, and empty columns in E and F) or were treated with 100 nM wortmannin for 30 min (C, D,
and black columns in E and F). The cells were allowed to internalize IgG-opsonized beads and the distribution of Rab7 was monitored by confocal
microscopy at the indicated times. (A and C) Phagocytosis was for 20 min, without chase. The arrows and arrowheads point to Rab7-GFP-positive
and -negative phagosomes, respectively. (B and D) Corresponding differential interference contrast images. Scale bars  10 m. (E and F)
Quantification of the effect of wortmannin on Rab7-GFP acquisition by phagosomes in CHO-IIA (E) and RAW cells (F). Empty columns, control;
black columns, cells treated with wortmannin. Data are means  SE (error bars) of four separate experiments, each with at least 100 individual
phagosomes from 30 to 40 different cells expressing low levels of Rab7-GFP counted per condition.
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bypass the inhibition. Conversely transfection of CA-Rab7
would be without effect if PI3K acts after or in parallel with
Rab7. The experiments addressing these alternatives are illus-
trated in Fig. 9. The CA-Rab7 was found to associate with
phagosomes in both control and, to a slightly lesser extent in
wortmannin-treated cells (Fig. 9A and D). Expression of the
active mutant did not interfere with the recruitment of
LAMP-1 by phagosomes in control cells (Fig. 9B) and, impor-
tantly, it failed to overcome the inhibitory effects of wortman-
nin on phagolysosome formation. As shown in Fig. 9G,
expression of CA-Rab7 had no detectable effect on LAMP-1
acquisition after 20 and 40 min and produced a marginal stim-
ulation at 60 min. Importantly, similar results were obtained
using RAW macrophages (not shown). These findings confirm
the notion that PI3K activity is required for a step(s) other
than Rab7 activation.
DISCUSSION
Treatment of macrophages with gamma interferon was
found to induce the biosynthesis of Rab5 and, in parallel, to
accelerate the intracellular killing of pathogens like Listeria
monocytogenes (3). In addition, Duclos and colleagues (15)
reported that heterologous expression of CA-Rab5 resulted in
the formation of enlarged phagosomes. On the basis of these
observations, and by analogy with the endosomal pathway, a
role for Rab5 in phagosome maturation had been suspected,
but it was not demonstrated. Here we present direct evidence
that active Rab5 is required for successful phagolysosome for-
mation (Fig. 5). Association of active Rab5 with phagosomes
precedes and is essential for the recruitment of Rab7, which in
turn precedes and is required for the fusion of phagosomes
with late endocytic compartments (R. E. Harrison and S. Grin-
stein, unpublished observations). While sequential recruitment
of active Rab5 and Rab7 to the phagosome is necessary, it is
not sufficient for completion of maturation. This is best illus-
trated in cells treated with wortmannin, where phagosomes
contain increased amounts of active Rab5 (Fig. 1) and upwards
of 60% of the normal complement of active Rab7 (Fig. 7)
yet fail to fuse with late endosomes and lysosomes to a signif-
icant degree. Clearly, one or more additional PI3K-dependent
events are also required for successful generation of phagoly-
sosomes.
The experiments reported here indicate that treatment with
wortmannin prevented neither the recruitment of Rab5 nor its
activation on the phagosomal membrane (Fig. 1 to 4), while it
completely eliminated PI(3)P from the phagosomal mem-
brane, as detected using FYVE or PX domain chimeras (not
illustrated). This implies that class I or III PI3K does not
provide the signal that targets Rab5 to the phagosome. In fact,
the amount of Rab5 detectable on phagosomes was greater in
wortmannin-treated cells than in controls, and its dwelling time
on the phagosomal membrane was prolonged. Three mecha-
nisms could account for these observations. (i) The activity or
availability of Rab5 anchors and activators on the phagosomal
membrane may increase upon inhibition of PI3K. This mech-
anism, however, is not consistent with the FRAP determina-
tions, which indicate that the primary cause of accumulation
is reduced dissociation, rather than increased association of
FIG. 8. RILP recruitment to phagosomes. CHO-IIA cells were cotransfected with wild-type Rab7-GFP and RILP-HA. (D to F) Cells were
treated with wortmannin 30 min before phagocytosis. Phagocytosis was allowed to proceed for 20 min, and this was followed by a 30-min chase.
The cells were then fixed and immunostained for the HA epitope. (A and D) Distribution of Rab7-GFP; (B and E) the distribution of RILP-HA;
(C and F) corresponding differential interference contrast images. The arrows point to phagosomes positive for both Rab7 and RILP. Asterisks
identify transfected cells. Bars  10 m. Results are representative of four similar experiments, each with 30 cells counted.
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Rab5 with the membrane. (ii) PI3K may be required for the
activation and/or recruitment of Rab5 GAPs to the phago-
some. At least three types of Rab5-GAPs have been described:
tuberin (38), Ras-GAP (27), and RN-tre (24). Of these, Ras-
GAP was reported to be directly inhibited by wortmannin by a
process that is independent of PI3K (10). While this proposed
mechanism would explain many of our data, we found that in
cells treated with the chemically unrelated PI3K inhibitor
LY294002, Rab5 accumulates in phagosomes in a manner that
closely mimics the effects of wortmannin (unpublished obser-
vations). We therefore believe that depletion of products of
PI3K, rather than direct inhibition of Ras-GAP, is responsible
for the altered behavior of Rab5. Of the GAPs listed above,
only RN-tre is specific towards Rab5 and therefore of the
greatest interest. RN-tre was found to localize primarily to the
plasma membrane and to reside in phagosomes only briefly
FIG. 9. Effect of constitutively active Rab7 on LAMP-1 acquisition by phagosomes. CHO-IIA cells were transfected with CA-Rab7-GFP and
either left untreated (A to C and empty columns in G) or treated with wortmannin (D to F and black columns in G) prior to phagocytosis. After
20 min of phagocytosis the unbound particles were removed and the cells were incubated for 30 more min to allow phagosome maturation. The
cells were then fixed, permeabilized, and immunostained with anti-LAMP-1 antibodies. (A and D) Distribution of CA-Rab7-GFP; (B and E)
distribution of LAMP-1. Arrows and arrowheads point to phagosomes that were positive or negative, respectively, for Rab7 or LAMP-1, as
appropriate. Asterisks identify transfected cell. Scale bars  10 m. (C and F) Corresponding differential interference contrast images. (G) Quan-
titation of LAMP-1 acquisition by phagosomes in cells treated with wortmannin. The graph compares cells that were untransfected (black bars)
with CA-Rab7-GFP-transfected cells (open bars). Data are means SE (error bars) of four separate experiments, each with at least 100 individual
phagosomes from 20 to 40 different cells counted per condition.
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(less than 5 min). The temporal pattern of association of RN-
tre with the phagosome was not visibly altered by treatment of
the cells with wortmannin (O. V. Vieira, unpublished observa-
tions). Hence, PI3K is not required for its targeting or main-
tenance in phagosomes. Alternatively, other GAPs or Rab-
GDI (guanine nucleotide dissociation inhibitor) may account
for the protracted activation of Rab5 in wortmannin-treated
cells; (iii) The removal of Rab5 from the phagosome may occur
by fission of vesicles containing the GTPase, rather than by the
canonical nucleotide hydrolysis and solubilization of the pro-
tein. In this scenario, PI3K may be required for fission to occur
and its inhibition would lead to Rab5 accumulation.
Products of PI3K are also required to recruit and/or activate
effectors of Rab5, such as EEA1 and rabenosyn 5 (29, 30, 34).
It is likely that impairment of one or more of these effectors
contributes to the inability of the early phagosome to fuse with
late endosomes and phagosomes. Regardless of the mode of
action of wortmannin on Rab5, our data suggest that the role
of PI3K is not limited to this step of the maturation cascade.
Because association of Rab7 follows that of Rab5, and because
inhibition of Rab7 impairs maturation, we suspected that re-
cruitment of Rab7 was the alternate target of PI3K. However,
we found that Rab7 acquisition by phagosomes was only par-
tially (40%) diminished by wortmannin (Fig. 7). We specu-
late that phagosomal Rab7 is acquired from 2 sources: one that
is independent of PI3K and may be the cytosolic pool or an
unidentified wortmannin-insensitive vesicular pool (purple
oval in Fig. 10), while another wave of Rab7 may merge with
the phagosomes when the latter fuse with late endosomes or
lysosomes, which are well established to carry the GTPase. To
the extent that fusion is precluded by wortmannin, the latter
component would be lacking in phagosomes treated with the
inhibitor.
The sizable fraction of Rab7 that associates with the phago-
some in wortmannin-treated cells appears to be functionally
active, as indicated by its ability to recruit RILP, an effector
thought to interact only with the GTP-bound form of Rab7 (8).
It would therefore appear that active Rab7 is not, per se,
sufficient to mediate fusion of the phagosomes with late endo-
somes and lysosomes. Accordingly, the expression of CA-Rab7
failed to bypass the block exerted by wortmannin (Fig. 9). One
could conclude from these observations that wortmannin is
effecting the block of maturation downstream of Rab7. How-
ever, it is equally possible that two parallel inputs are required
to trigger proper fusion of endosomes or lysosomes with the
phagosome: one mediated by Rab7 and another that includes
FIG. 10. Schematic representation of phagosome maturation, highlighting putative sites of action of PI3K. Nascent phagosomes formed upon
fission from the plasma membrane contain small amounts of Rab5. Additional Rab5 is acquired by fusion with early endosomes. Inhibition of PI3K
prevents the dissociation of active Rab5 from early phagosomes and presumably also from early endosomes (dotted line). Recruitment or acti-
vation of (some) Rab5 effectors also requires products of PI3K. Intermediary phagosomes are formed upon acquisition of Rab7 from either the
soluble pool or from a PI3K-independent vesicular compartment. Late phagosomes form by fusion with late endosomes, which themselves bear
Rab7. This step is blocked by wortmannin. Late phagosomes become phagolysosomes upon fusion with lysosomes. Wortmannin also prevents this
step. A putative Rab7-bearing organelle that can still fuse with phagosomes despite the presence of PI3K inhibitors is indicated by the purple oval
(lower left).
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the PI3K-dependent event, likely the activation of Rab5 effec-
tors, yet does not involve Rab7. Because RILP was recently
shown to bridge between dynein and Rab7-containing cargo, it
is possible that the Rab7 arm is involved in mechanically po-
sitioning phagosomes in the vicinity of late endosomes/lyso-
somes, while another, PI3K dependent step is required for the
actual fusion event. In this context, it is noteworthy that, at
least in yeast, the association of SNAREs like Vam7 with
membranes of the endocytic pathway requires interaction with
PI(3)P, a product of class III PI3K (9). Moreover, SNAREs
can associate with activated Rab5 in mammalian systems (28).
These concepts are synthesized in diagrammatic form in Fig.
10. Nascent phagosomes are shown to contain some Rab5,
present originally in the invaginating plasma membrane and/or
recruited there by activated Fc receptors. Additional Rab5 is
acquired by fusion with early endosomes, but mostly from the
soluble pool, since experiments using Rab5-GFP showed rapid
gain of phagosomal fluorescence that was not accountable by
fusion with labeled vesicular compartments (31). Wortmannin
is shown to interfere with the dissociation of the active (GTP-
bound) form of Rab5 from early phagosomes and presumably
also from early endosomes. Rab5 is shown in the diagram to
recruit two types of effectors: some that are PI3K independent
and others that require PI3K products for recruitment and/or
activation. Rab5-enriched early phagosomes then proceed to
become intermediary phagosomes by shedding Rab5 and ac-
quiring Rab7. We propose that the PI3K-independent effectors
of Rab5 take part in the recruitment of Rab7. Rab7 is recruited
initially from the cytosol and/or from an unidentified vesicular
compartment distinct from late endosomes and lysosomes.
Next, the Rab7-enriched phagosome fuses with late endo-
somes by a 3	-phosphoinositide-dependent process, perhaps
involving Rab5 effectors, generating late phagosomes. These,
in turn coalesce with lysosomes by a process that also requires
PI3K. It is not clear whether this is a distinct PI3K-dependent
step, or the manifestation of the inability of the phagosome to
reach the late stage, which may be essential for fusion with
lysosomes. Merger with late endosomes and lysosomes delivers
to the phagosome additional Rab7 that is constitutively present
in these organelles. The latter component of Rab7 recruitment
is therefore wortmannin sensitive, accounting for the partial
effects of the inhibitor. The ultimate stage of the process is the
formation of phagolysosomes, which have optimal microbicidal
properties. An essential feature of this model is the parallel
operation of two types of effectors, some that are PI3K depen-
dent and others that are independent.
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